Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 06:22 am Purchase |
2024-09-30 | 13G | Neurogene Inc. NGNE |
RTW Investments, LP | 1,135,256 8.700% |
1,135,256 (New Position) |
Filing History |
| 2024-11-14 06:19 am Sale |
2024-09-30 | 13G | Vericel Corporation VCEL |
RTW Investments, LP | 0 0.000% |
-3,212,794 (Position Closed) |
Filing History |
| 2024-11-14 06:17 am Sale |
2024-09-30 | 13G | Pharming Group N.V. PHAR |
RTW Investments, LP | 0 0.000% |
-38,496,391 (Position Closed) |
Filing History |
| 2024-11-14 06:15 am Sale |
2024-09-30 | 13G | Fulcrum Therapeutics, Inc. FULC |
RTW Investments, LP | 0 0.000% |
-5,469,956 (Position Closed) |
Filing History |
| 2024-11-14 06:12 am Sale |
2024-09-30 | 13G | Celldex Therapeutics, Inc. CLDX |
RTW Investments, LP | 0 0.000% |
-3,463,201 (Position Closed) |
Filing History |
| 2024-11-14 06:10 am Sale |
2024-09-30 | 13G | Avadel Pharmaceuticals plc AVDL |
RTW Investments, LP | 0 0.000% |
-9,196,186 (Position Closed) |
Filing History |
| 2024-11-14 06:07 am Sale |
2024-09-30 | 13G | Adicet Bio, Inc. ACET |
RTW Investments, LP | 0 0.000% |
-4,134,631 (Position Closed) |
Filing History |
| 2024-10-24 5:19 pm Sale |
2024-10-22 | 13D | Allurion Technologies Inc. ALUR |
RTW Investments, LP | 146,664 5.700% |
-30,000 (-16.98%) |
Filing History |
| 2024-08-23 5:46 pm Purchase |
2024-08-22 | 13D | Avidity Biosciences, Inc. RNA |
RTW Investments, LP | 12,079,734 9.990% |
2,419,925 (+25.05%) |
Filing History |
| 2024-08-07 5:19 pm Purchase |
2024-08-05 | 13D | Orchestra BioMed Holdings, Inc. OBIO |
RTW Investments, LP | 7,704,030 21.500% |
2,083,385 (+37.07%) |
Filing History |
| 2024-07-02 5:51 pm Purchase |
2024-06-28 | 13D | Allurion Technologies Inc. ALUR |
RTW Investments, LP | 176,663 7.000% |
19,187 (+12.18%) |
Filing History |
| 2024-04-17 6:57 pm Purchase |
2024-04-16 | 13D | Allurion Technologies Inc. ALUR |
RTW Investments, LP | 157,476 8.100% |
157,476 (New Position) |
Filing History |
| 2024-03-01 4:15 pm Purchase |
2024-02-28 | 13D | Avidity Biosciences, Inc. RNA |
RTW Investments, LP | 9,659,809 9.990% |
2,958,320 (+44.14%) |
Filing History |
| 2024-02-14 07:57 am Purchase |
2023-12-31 | 13G | Immunocore Holdings plc IMCR |
RTW Investments, LP | 6,096,387 12.300% |
537,065 (+9.66%) |
Filing History |
| 2024-02-14 07:55 am Purchase |
2023-12-31 | 13G | Immunic, Inc. IMUX |
RTW Investments, LP | 4,335,255 9.600% |
473,965 (+12.27%) |
Filing History |
| 2024-02-14 07:53 am Purchase |
2023-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
RTW Investments, LP | 5,469,956 8.800% |
476,677 (+9.55%) |
Filing History |
| 2024-02-14 07:52 am Sale |
2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
RTW Investments, LP | 0 0.000% |
-4,356,920 (Position Closed) |
Filing History |
| 2024-02-14 07:49 am Sale |
2023-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
RTW Investments, LP | 0 0.000% |
-2,067,824 (Position Closed) |
Filing History |
| 2024-02-14 07:47 am Purchase |
2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
RTW Investments, LP | 5,315,514 9.200% |
1,723,528 (+47.98%) |
Filing History |
| 2024-02-14 07:46 am Purchase |
2023-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
RTW Investments, LP | 6,887,086 8.400% |
2,920,171 (+73.61%) |
Filing History |